Home Tags Patents

Tag: Patents

Reverse Payments After Actavis

John Bigelow, Sep 30, 2013 Thirteen years ago-in 2000-the Federal Trade Commission ("FTC") and private plaintiffs began fighting certain kinds of settlements that sometimes arise...

The Evolution of U.S. Antitrust Agencies’ Approach to Standards and Standard...

This article is part of a Chronicle. See more from this Chronicle James Rill, Sep 16, 2015 The focus of this article is on what has...

Reverse Payments Post Actavis: A Litigation Quagmire?

This article is part of a Chronicle. See more from this Chronicle Keith Hylton, Jul 15, 2015 For the last decade or so, the FTC has...

Standard Setting, Patents, and Competition Law Enforcement—The Need for U.S. Policy...

This article is part of a Chronicle. See more from this Chronicle Alden Abbott, Mar 16, 2015 The setting of industry standards is widely recognized as...

Antitrust Regulation of IPRs: China’s First Proposal

Aug 14, 2014 CPI Asia Column edited by Vanessa Zhang (Global Economics Group) presents: Antitrust Regulation of IPRS – China’s First Proposal - Adrian Emch (Hogan...

What You Need To Know About Standard Essential Patents

This article is part of a Chronicle. See more from this Chronicle Michael Carrier, Aug 22, 2014 In the past several years, standard essential patents, or...

New Jersey District Court Limits Actavis To Cash Payments

This article is part of a Chronicle. See more from this Chronicle Donald Falk, Christopher Kelly, Apr 29, 2014 As with patent infringement litigation in many...

Appropriating the Returns from Industrial Research and Development (1950)(reprint)

Dec 20, 2013 To have the incentive to undertake research and development, a firm must be able to appropriate returns sufficient to make the investment...

An Introduction to Appropriating the Returns from Industrial Research and Development

David Evans, Dec 20, 2013 There are several areas of economics where we know much more today than we did 50 years ago as a...

Pay-for-Delay

Fiona Scott Morton, Dec 20, 2013 This article lays out the economics of competition between branded and generic pharmaceuticals and its welfare consequences. I explain...

News

Antitrust Mix by CPI